FDA.reportPublic FDA data

loteprednol etabonate 0.25 % Ophthalmic Suspension

RxCUI
2464838
RxNorm name
loteprednol etabonate 0.25 % Ophthalmic Suspension
Display name
loteprednol etabonate 0.25 % Ophthalmic Suspension
Full name
loteprednol etabonate 0.25 % Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EysuvisLOTEPREDNOL ETABONATEALCON LABORATORIES, INC.a2169d82-4275-4ab6-a1c3-c274080b815c2025-03-11Warnings, Adverse reactionsExact identifier
rxcui: 2464838

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a2169d82-4275-4ab6-a1c3-c274080b815cloteprednol etabonate 0.25 % Ophthalmic Suspension [PSN] · loteprednol etabonate 2.5 MG/ML Ophthalmic Suspension [SCD] · loteprednol etabonate 0.25 % Ophthalmic Suspension [SY]310These highlights do not include all the information needed to use EYSUVIS™ safely and effectively. See full prescribing information for EYSUVIS. EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, for topical ophthalmic use Initial U.S. Approval: 199820250311